You are now leaving the www.mirena-us.com website.

Bayer Healthcare Pharmaceuticals Inc. is not responsible for the content presented by any independent website, including any advertising claims, special offers, illustrations, names or endorsements.

Thank you for visiting www.mirena-us.com.

OKCancel
The requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe® Acrobat® Reader®. If you already have Adobe Acrobat Reader installed click "VIEW PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.

View PDF Cancel

Don't show me this message again.
Healthcare Professionals
Go

Mirena® Press Room

After being used for a decade in Europe by millions of women, Mirena® intrauterine contraceptive became available in the United States in 2001. Over the past 16 years, more than 10 million women worldwide have used Mirena® successfully.

Information on Intrauterine Contraception with Mirena®

Mirena® in the News

Bayer Healthcare Contact Information (For Media inquiries only)

Heather Levis
Manager, Public Relations
973-305-5313

Rose Talarico
Associate Director, Public Relations
973-305-5302

For other questions about Mirena®, please call (toll-free) 1-888-84-BAYER (1-888-842-2937).


IMPORTANT INFORMATION ABOUT MIRENA®:
Only you and your healthcare professional can decide if Mirena is right for you. Mirena does not protect against HIV or sexually transmitted diseases (STDs). Candidates for Mirena have had a child. Mirena is not appropriate for women who are or may be pregnant; or who may have a distorted uterine cavity; acute genital infections including pelvic inflammatory disease; cancer of the cervix, uterus, or breasts; unexplained vaginal bleeding; or acute liver disease or tumors (benign or malignant). In rare cases, perforation or embedment may occur. Mirena may become completely or partially dislodged. In the rare event you think you're pregnant, contact your healthcare professional without delay to be evaluated for ectopic pregnancy. Ovarian cysts may occur and typically disappear. Persistent cysts should be evaluated. Missing periods or irregular bleeding is common in the first few months, followed by shorter, lighter periods.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.